Novel RNA delivery system may treat incurable blood cancers
With a median survival rate of just five to seven years, Mantle Cell Lymphoma (MCL) is considered the most aggressive known blood cancer—and available therapies are scarce. Three thousand Americans are diagnosed with MCL ...
Jan 5, 2016
0
107